Contribution: Industrial Research Assistance Program – Contributions to Firms
BioLytical Laboratories Inc.
$430,475.00
Development of Rapid Diagnostic Tests for Hepatitis C Virus Infections
FY 2018-19 · 2018-08-15
Summary
This project will develop a rapid point of care diagnostic test designed to detect hepatitis C virus (HCV) antibody and/or antigen from human blood, plasma and serum.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Richmond|Richmond, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
869859116
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-08-15 | 2018-19 | $244,135.00 |
| 1 | 2018-08-15 | 2018-19 | $289,545.00 |
| 2 | 2018-08-15 | 2018-19 | $329,545.00 |
| 3 | 2018-08-15 | 2018-19 | $289,545.00 |
| 4 | 2018-08-15 | 2018-19 | $430,475.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 80 days. The total amended value is 100,930 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 80 jours. La valeur totale des modifications est de 100 930 dollars.
Agreement End Date
2020-03-20
Agreement Number
911989
Agreement Start Date
2018-08-15
Agreement Title
Development of Rapid Diagnostic Tests for Hepatitis C Virus Infections
Agreement Title (French)
Développement de tests de diagnostic rapides pour les infections à virus de l'hépatite C
Agreement Type
Contribution
Agreement Value
$430,475.00
Amendment Date
2020-01-02
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will develop a rapid point of care diagnostic test designed to detect hepatitis C virus (HCV) antibody and/or antigen from human blood, plasma and serum.
Description (French)
Ce projet développera un test de diagnostic rapide sur le lieu de soins conçu pour détecter les anticorps et / ou antigènes du virus de l'hépatite C (VHC) dans le sang, le plasma et le sérum humains.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Steveston--Richmond East
Federal Riding (French)
Steveston--Richmond-Est
Federal Riding Number
59031
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
869859116
Recipient City
Richmond|Richmond
Recipient Country
CA
Recipient Legal Name
BioLytical Laboratories Inc.
Recipient Postal Code
V6V 2X7
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q2-911989
